At Pittcon 2024, LCGC International editor Patrick Lavery sat down with Michael Marty of the University of Arizona to talk about the ongoing work in his laboratory.
Dr. Michael Marty is an Associate Professor of Chemistry & Biochemistry at the University of Arizona. He earned his PhD in chemistry at the University of Illinois Urbana-Champaign as a Springborn Fellow under the guidance of Prof. Stephen Sligar. Following his doctoral studies, he conducted postdoctoral research at the University of Oxford with Prof. Dame Carol Robinson before joining the University of Arizona in 2016.
Dr. Marty is best known for his contributions to the field of membrane protein biochemistry through native mass spectrometry (MS). One of his notable achievements was his development of the UniDec software platform, which is capable of enhancing the analysis of native mass spectra. His research has yielded over 50 peer-reviewed publications in prestigious journals such as the Journal of the American Chemical Society, Analytical Chemistry, & the Journal of the American Society of Mass Spectrometry.
He has been honored with several awards over the years, including the NSF Career Award, an ASMS Research Award, and the ASMS Ron Hites Award. Notably, he was granted the Pittcon Achievement Award at Pittcon 2024, recognizing his outstanding accomplishments in applied spectroscopy and analytical chemistry over the past decade.
LCGC International sat down with Marty to discuss the following topics:
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
Trending on LCGC: The Top Content of 2024
December 30th 2024In 2024, we launched a content series, covered major conferences, presented prestigious awards, and continued our monthly Analytically Speaking podcasts. Below, you'll find a selection of the most popular content from LCGC International over the past year.